Raymond James Financial Services Advisors’s Lantern Pharma LTRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-10,896	Closed	-$50.9K	–	3482
2024 Q2	$50.9K	Sell	10,896 -1,108	-9%	-$5.17K	﹤0.01%	3284
2024 Q1	$106K	Buy	+12,004	New	+$106K	﹤0.01%	3213